Current Treatment Outcomes in Japanese RCC Patients Treated With Avelumab Plus Axitinib as First-line Therapy: Retrospective Study (J-DART)

Clinical trial NCT05012865 · COMPLETED

Trial details

NCT number: NCT05012865
Sponsor: Pfizer
Status: COMPLETED
Study type: OBSERVATIONAL

Renal Cell Carcinoma

Start date: 2021-09-14
Primary completion: 2022-01-31
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.